Loading...
Price History
Market Data
| Market Cap | 123.52B |
| P/E Ratio | - |
| P/B Ratio | 1.64 |
| EPS | - |
| Dividend Yield | 2.74% |
| D/E Ratio | 2.37 |
| Current Ratio | 0.84 |
| Currency | USD |
Key Financial Metrics
402.07B
Revenue
1.77B
Net Income
-
EPS (Diluted)
16.72B
Free Cash Flow
Profitability
Gross Margin
45.0%
Operating Margin
1.2%
Net Profit Margin
0.4%
EBITDA
9.27B
Returns & Efficiency
Return on Assets (ROA)
0.7%
Return on Equity (ROE)
2.4%
Dividend Yield
2.74%
EPS
-
Financial Health
Total Assets
253.54B
Total Debt
60.50B
Debt to Equity
2.37x
Current Ratio
0.84
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| HQ | WOONSOCKET, RI |
| Fiscal Year | 2025 |
Peers
BIOSCRIP, INC.
OPCH
3.53B
P/E: --
2.47B
P/E: 44.9
2.47B
P/E: 44.9
PETMED EXPRESS INC
PETS
39.33M
P/E: --
6.50M
P/E: --
1.83M
P/E: --
1.83M
P/E: --
--
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$123.52B
P/E Ratio (TTM)-
Price to Book1.64
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin45.0%
Operating Margin1.2%
Net Margin0.4%
ROE2.4%
ROA0.7%
Leverage & Liquidity
Debt to Equity2.37
Current Ratio0.84
Total Debt$60.50B
Total Assets$253.54B
Stockholders' Equity$75.21B
Income Statement (FY 2025)
Revenue$402.07B
Gross Profit$180.90B
Operating Income$4.66B
Net Income$1.77B
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$16.72B
Cash & Equivalents$8.45B
Revenue Growth7.8%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | ONE CVS DR. WOONSOCKET, RI 02895 |
| Phone | 4017651500 |
| Incorporated | DE, US |
| EIN | 050494040 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 1.27B |
| Stockholders' Equity | $75.21B |
| Cash & Equivalents | $8.45B |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-11
Local
13F-HR
13F-HR Filing
SEC regulatory filing
Filed: 2026-05-07
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-06
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-06
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
3
Initial Ownership Report
Initial statement of beneficial ownership of securities
Filed: 2026-03-19
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-19
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-02
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-02
Local
13F-HR
13F-HR Filing
SEC regulatory filing
Filed: 2026-02-13
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-10
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-10
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-10-29
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-07-31
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | CVS HEALTH CORP |
| Ticker | CVS |
| Exchange | -- |
| Sector | Retail Trade |
| Industry | -- |
| Headquarters | WOONSOCKET, RI |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 123.52B |
| Revenue | 402.07B |
| Net Income | 1.77B |
| P/E Ratio | - |
| EPS | - |
| Net Margin | 0.4% |
| ROE | 2.4% |
| Dividend Yield | 2.74% |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...